[Abstract Only] Randomized Trial: Improved Overall Survival with Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma 15 May, 2020 | 03:23h | UTC Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma – New England Journal of Medicine See also: Visual Abstract